2-Methoxyestradiol Induces G2/M Arrest and Apoptosis in Prostate Cancer
- 1 August 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 285 (5) , 1259-1266
- https://doi.org/10.1006/bbrc.2001.5320
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Hepatocyte Growth Factor and Vitamin D Cooperatively Inhibit Androgen-Unresponsive Prostate Cancer Cell Lines*Endocrinology, 2000
- Chemotherapy for patients with advanced prostate carcinomaCancer, 2000
- 2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug CandidateCancer and Metastasis Reviews, 2000
- THE BIOLOGY OF HORMONE REFRACTORY PROSTATE CANCERUrologic Clinics of North America, 1999
- Hormone Resistance in Prostate CancerCancer and Metastasis Reviews, 1998
- 2-Methoxyestradiol Arrests Cells in Mitosis without Depolymerizing TubulinBiochemical and Biophysical Research Communications, 1996
- Induction of Apoptosis by Diethylstilbestrol in Hormone-Insensitive Prostate Cancer CellsJNCI Journal of the National Cancer Institute, 1996
- 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.Proceedings of the National Academy of Sciences, 1994
- The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growthNature, 1994
- Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762Journal of Urology, 1986